Economics of the Management of Craniospinal Chordoma and Chondrosarcoma and the feasibility of the bundled payment model.
Zaid AljubooriBeatrice UgiliwenezaDengzhi WangNorberto AndaluzMaxwell BoakyeBrian WilliamsPublished in: BMC neurology (2020)
The management of craniospinal chordoma and chondrosarcoma is costly and may extend over a prolonged period. The success of BPCI requires a joint effort between insurers and hospitals. Also, it should consider patients' comorbidities, the complexity of the disease. Finally, the adoptionof quality improvement programs by hospitals can help with cost reduction.